Laddar...
Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?
The optimal choice of cancer therapy depends upon analysis of the tumor genome for druggable molecular alterations. The spatial and temporal intratumor heterogeneity of cancers creates substantial challenges, as molecular profile depends on time and site of tumor tissue collection. To capture the en...
Sparad:
| I publikationen: | Expert Rev Mol Diagn |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5016094/ https://ncbi.nlm.nih.gov/pubmed/26559503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737159.2015.1110021 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|